Pre-Clinical Imaging Market by Systems & Reagents - 2019

MarketsandMarkets Presents

Pre-Clinical Imaging Market by Systems & Reagents - 2019

http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market841.html

The report “Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019� analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

Browse 84 market data tables, 65 figures spread through 184 pages and in-depth TOC http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imagingmarket-841.html Early buyers will receive 10% customization in this report This report studies the global pre-clinical imaging market over the forecast period of 2014 to 2019. The market is expected to reach $797 million by 2019, at CAGR of 6.0% from 2014 to 2019.

http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market841.html

On the basis of products, the global pre-clinical imaging market is segmented into two broad categories, namely, systems and reagents.

The systems market is divided into seven imaging modalities, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The pre-clinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems.

The pre-clinical nuclear imaging systems market consists of micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and trimodality (PET/SPECT/CT) imaging systems.

Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=841

http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market841.html

The reagents market has also been classified into five categories, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further subsegmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as pre-clinical PET tracers and SPECT probes.

A number of factors such as technological developments in molecular imaging technologies such as PET and MRI, rising acceptance of preclinical imaging as a legitimate drug development tool, and increasing number of pre-clinical research activities are propelling the growth of the global pre-clinical imaging market.

Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=841

http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market841.html

As of 2014, North America holds the largest share of the global pre-clinical imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2014 to 2019. A number of factors, including rising R&D activities by big pharma and biotech companies in developing nations, increased government funding for development of pharmaceutical industry, and growing number of CROs in emerging markets are stimulating the growth of the pre-clinical imaging market in the Asia-Pacific region.

Aspect Imaging (Israel), Biospace Lab S.A. (France), Bruker Corporation (U.S.), LI-COR Biosciences (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd (U.K.), PerkinElmer, Inc. (U.S.), TriFoil Imaging (U.S.), and FUJIFILM VisualSonics, Inc. (Canada) are the key players operating in the global pre-clinical imaging systems and reagents market.

Buy Now: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=841

http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market841.html

About MarketsandMarkets MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market841.html

Contact Us Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets